Skip to main content

Weighing Benefits and Challenges to Effectively Treat Atopic Dermatitis

September 16, 2020

logoSteven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying patient adherence.

Eichenfield LF, Armstrong A, Guttman-Yassky E, et al. Real-world effectiveness of dupilumab based on investigator global assessment (IGA) scores and peak pruritus numerical rating scale (PNRS) in an electronic medical records dataset. Poster presented at the 77th Annual Meeting of the Society for Investigative Dermatology (SID); May 8–11, 2019; Chicago, ILP.

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
7 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top